IRIS
GROSSI, Laurino
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3977
EU - Europa 3698
AS - Asia 1906
Continente sconosciuto - Info sul continente non disponibili 21
SA - Sud America 4
AF - Africa 3
Totale 9609
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3968
CN - Cina 964
UA - Ucraina 814
IT - Italia 615
TR - Turchia 557
SE - Svezia 554
GB - Regno Unito 466
FR - Francia 382
IN - India 343
IE - Irlanda 340
DE - Germania 231
FI - Finlandia 151
AT - Austria 46
PL - Polonia 35
BE - Belgio 22
VN - Vietnam 22
EU - Europa 20
RO - Romania 15
RU - Federazione Russa 9
CA - Canada 7
IL - Israele 6
GR - Grecia 5
AL - Albania 3
CL - Cile 3
ES - Italia 3
IR - Iran 3
KR - Corea 3
NO - Norvegia 3
JP - Giappone 2
MX - Messico 2
NL - Olanda 2
SG - Singapore 2
AE - Emirati Arabi Uniti 1
AP - ???statistics.table.value.countryCode.AP??? 1
BR - Brasile 1
EG - Egitto 1
ID - Indonesia 1
KH - Cambogia 1
LU - Lussemburgo 1
MA - Marocco 1
MU - Mauritius 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
Totale 9609
Salva come PNG Salva come JPEG
Città #
Jacksonville 943
Chandler 779
Dearborn 468
Southend 378
Princeton 354
Dublin 340
Nanjing 284
Izmir 272
Wilmington 254
Beijing 169
Cambridge 157
Woodbridge 119
Ann Arbor 115
Nanchang 93
Houston 61
Hebei 53
Boardman 49
Shenyang 48
Altamura 47
Kunming 45
Vienna 45
Tianjin 43
Jiaxing 40
Rome 36
Kraków 35
Chieti 29
Hefei 28
Hangzhou 27
Bologna 25
Norwalk 25
Dong Ket 22
Brussels 21
Düsseldorf 20
Jinan 20
Changsha 18
Orange 18
Bellante 15
Grevenbroich 14
Guangzhou 14
Lanzhou 14
Pescara 12
Fuzhou 11
Falls Church 10
Cepagatti 9
Changchun 9
Ningbo 8
L'aquila 7
Mumbai 7
Varallo 7
Milan 6
Ashburn 5
Auburn Hills 5
Ripa Teatina 5
Seattle 5
Helsinki 4
Los Angeles 4
Redwood City 4
Senigallia 4
Siena 4
Simi Valley 4
Sulmona 4
Walnut 4
Xian 4
Zhengzhou 4
Avezzano 3
Baotou 3
Cedar Knolls 3
Duncan 3
London 3
Marseille 3
Taizhou 3
Teramo 3
Verona 3
Amsterdam 2
Aprilia 2
Ardea 2
Augusta 2
Campofranco 2
Carovilli 2
Castelnuovo Rangone 2
Cori 2
Dallas 2
Edmonton 2
Ercolano 2
Fairfield 2
Francofonte 2
Genova 2
Giovinazzo 2
Guadalajara 2
Haikou 2
Kirkland 2
Leawood 2
Lecce 2
Macomer 2
Magnago 2
Mcallen 2
Mexico 2
Monmouth Junction 2
Monte San Pietro 2
Mountain View 2
Totale 5764
Salva come PNG Salva come JPEG
Nome #
Il tempo di transito oro-cecale (TTOC) è accelerato dopo somministrazione orale di allergene alimentare nei pazienti con sindrome del colon irritabile (SCI) e prick test positivo 342
Blood cardioplegia: could it protect the ischemic-reperfused human myocardium through antioxidant-type mechanisms? 94
Trasmissione di Helicobacter pylori in un modello murino 94
A Triple and Quadruple Therapy with Doxycycline and Bismuth for First-Line Treatment of Helicobacter pylori Infection: A Pilot Study 94
Helicobacter pylori isolates from proximal and distal stomach of patients never treated and already treated show genetic variability and discordant antibiotic resistance. 92
SR140333, a substance P receptor antagonist, influences morphological and motor changes in rat experimental colitis 91
EFFICACY OF TREATMENT WITH PYLERA IN COMBINATION WITH RANITIDINE ON FIRST-LINE INFECTION HELICOBACTER PYLORI: EXPERIENCE OF A SINGLE CENTER 89
In vitro antimicrobial susceptibility of Helicobacter pylori to nine antibiotics currently used in Central Italy 88
24-hour pancolonic motility using a portable electronic probe in healthy subjects 86
48-Hour continuous pH measurement in patients with gastro-oesophageal reflux: effect of cisapride. 86
Treatment of Helicobacter pylori (Hp) infection with an association of Omeprazole and Roxytromicine: a study in vivo and in vitro. 86
USO DI GOLIMUMAB COME SECONDA LINEA BIOLOGICA IN UN PAZIENTE CON RETTOCOLITE ULCEROSA 84
Two weeks regimen with amoxillicin, tinidazole and omeprazole eradicates helicobacter pylori and cures active duodenal ulcer 83
SYMPTOM PATTERN IN FUNCTIONAL DYSPEPSIA AND GASTROESOPHAGEAL REFLUX DISEASE: ROLE OF H. PYLORI INFECTION 83
Correlation between anal canal size and anal canal pressure: an ultrasonografhip and manometric study 77
Transmission of Helicobacter pylori in an animal model. 76
Morphological and motor changes during experimental colits in rats are prevented by a specific substance p antagonist 76
ITALIAN REAL-LIFE STUDY EVALUATING THE LONG-TERM EFFECTIVENESS OF VEDOLIZUMAB FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE: THE ELDERLY COHORT 76
null 76
Alterazioni non litiasiche del contenuto colecistico 74
TRANSIENT LOWER ESOPHAGEAL SPHINCTER RELAXATIONS AND GASTRO-ESOPHAGEAL REFLUX EPISODES IN HEALTHY SUBJECTS AND GERD PATIENTS DURING 24 HOURS 72
THERAPY-RELATED ADVERSE EVENTS IN CROHN’S DISEASE (CD) – A COMPARISON BETWEEN THIOPURINES, INFLIXIMAB AND COMBINED THERAPY 72
ESOPHAGITIS AND ITS CAUSES: WHO IS "GUILTY" WHEN ACID IS FOUND "NOT GUILTY"? 72
Short- and long-term omeplazole for the tratment and prevention of duodenal ulcer, and effect on helicobacter pylori 71
Effect of omeprazole, clarithromicin and amoxicillin for a short time on helicobacter pylori eradication 71
FUSOBACTERIUM NUCLEATUM (FN) IN PATIENTS AFFECTED BY INFLAMMATORY BOWEL DISEASE 71
Diameters and pressures of the anal canal simultaneously measured with endosonography and manometry 70
TYPICAL AND ATYPICAL SYMPTOMS OF GASTRO ESOPHAGEAL REFLUX DISEASE: DOES Helicobacter pylori MATTER? 70
Role of antimicrobial susceptibility testing on efficacy of triple therapy in Helicobacter pylori eradication. 69
Distribuzione transmurale dei sistemi antiossidanti e della perossidazione lipidica nel ventricolo sinistro di coniglio 69
Swallows, oesophageal and gastric motility in normal subjects and in patients with gastro-oesophageal reflux disease: a 24-h-pH-manometric study 68
Effect of glyceryl trinitrate ointment (GTO) 0.2% and 2% on anal canal pressure during acute and chronic application in patients with anal fissure 68
H2-RECEPTOR ANTAGONISTS ARE SCAVENGERS OF OXYGEN RADICALS 68
EFFICACY AND SAFETY OF LONG-TERM INFLIXIMAB USE FOR CROHN’S DISEASE IN SOUTHERN ITALY 68
EFFECT OF CLEBOPRIDE ON ESOPHAGEAL MOTOR FUNCTION IN GERD PATIENTS WITH INEFFECTIVE ESOPHAGEAL MOTILITY: EVALUATION USING HIGH RESOLUTION MANOMETRY 68
THERAPY- RELATED ADVERS EVENTS IN CROHN’S DISEASE (CD) – A COMPARISON BETWEEN THIOPURINES, INFLIXIMAB AND COMBINED THERAPY 68
REAL-LIFE STUDY (GORE-UC) EVALUATING THE EFFECTIVENESS OF GOLIMUMAB FOR THE TREATMENT OF ULCERATIVE COLITIS: AN INTERIM ANALYSIS FROM ITALIAN GROUP FOR THE STUDY OF INFLAMMATORY BOWEL DISEASE (IG-IBD). 68
Anal canal diameters and pessure measured simultaneously by real time ultrasonography and manometry in human subjects 67
Esophageal and gastric motility in patients with gastroesophageal reflux disease 67
GRAVIDANZA IN UNA PAZIENTE AFFETTA DA RETTOCOLITE ULCEROSA IN TERAPIA CON INFLIXIMAB: CASO CLINICO 67
RISPOSTA CLINICA E GUARIGIONE DELLA MUCOSA DOPO 4 ANNI DI TERAPIA CON INFLIXIMAB IN UN PAZIENTE CON MALATTIA DI CROHN ILEALE STEROIDO-RESISTENTE 67
EFFICACY AND SAFETY OF INFLIXIMAB IN THE LONG-TERM IN CROHN’S DISEASE 67
Evidence for an oro-fecal transmission inan experimental murine model of helicobacter pylori infection. 65
Beneficial effects of SR140333, a novel substance P antagonist, in a rat model of experimental colitis 65
Detection of Helicobacter pylori in the gastrointestinal tract of Balb/C euthymic mice infected by human Helicobacter pylori and evidence for transmission 65
EVALUATION OF LIVER BLOOD FLOW AND FIBROSIS IN PATIENTS WITH NON ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND CIRRHOSIS IN COMPARISON WITH NORMAL CONTROLS THROUGH CONTRAST ENHANCED ULTRASOUND(CEUS) AND FIBROSCAN 65
EVALUATION OF INTRAPARENCHYMAL AND PORTAL BLOOD FLOW BY CONTRAST ENHANCED ULTRASOUND (CEUS) AND LIVER STIFFNESS BY FIBROSCAN IN NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND CHRONIC HEPATITIS C (CHC) 65
Pharyngeal, Esophageal and Gastric Motility in Normal Subjects and in patients with gastroesophageal Reflux Disease 64
Gastric antral and fundus receptive relaxation in dyspeptic patients and normal subjects 64
I RILASCIAMENTI TRANSITORI DELLO SFINTERE ESOFAGEO INFERIORE NELLA GENESI DEI REFLUSSI GASTRO-ESOFAGEI: PROSPETTIVE TERAPEUTICHE 64
EVALUATION OF INTRAPARENCHYMAL AND PORTAL BLOOD FLOW BY CONTRAST ENHANCED ULTRASOUND (CEUS) AND LIVER STIFFNESS BY FIBROSCAN IN NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND CHRONIC HEPATITIS C (CHC). 64
LA MALDIGESTIONE 63
SHORT AND LONG TERM EFFICACY OF GLYCERYL TRINITRATE (GTN) OINTMENT 0.2% AND 2% ON ANAL CANAL PRESSURE IN PATIENTS WITH CHRONIC ANAL FISSURES. 63
THE INFLUENCE OF ACID REFLUX ON THE HEART RATE VARIABILITY (HRV) IN PATIENTS WITH AND WITHOUT GASTROESOPHAGEAL REFLUX DISEASE (GERD) 63
COMBINED VIDEOCAPSULE ENDOSCOPY (VCE) AND LACTULOSE HYDROGEN BREATH TEST (LHBT): A COMPARATIVE STUDY TO ASSESS ORO-CECAL TRANSIT TIME (OCTT). 63
Effect of omeprazole, clarithromicin and amoxicillin for a short time on helicobacter pylori eradication 62
Distensione gastrica nei soggetti normali e nei pazienti dispeptici helicobacter pylori positivi e negativi e correlazione con i sintomi 62
Proximal and Distal Gastric Distension in Normal Subjects and H.pylori-Positive and -Negative Dyspeptic Patients and Correlation with Symptoms 62
Peppermint oil (Mintoil®) in the treatment or irritable bowel syndrome: a prospective double blind placebo controlled randomized trial. 62
EVALUATION OF FIBROSIS AND INTRAPARENCHIMAL BLOOD FLOW INCHIRROTIC PATIENTS, CHRONIC ACTIVE HEPATITIS AND NORMAL CONTROLS THROUGH FIBROSCAN AND ULTRASOUND ENHANCED CONTRAST MEDIA. 62
SPONTANEOUS OPENING OF LES IN ACHALASIA: AN UNCOMMON ON-LINE DOCUMENTATION BY HIGH-RESOLUTION MANOMETRY 62
Oesophageal and gastric motility in patients with gastro-oesophageal reflux disease 61
Anti-Helicobacter pylori specific antibody immunohistochemistry improves the diagnostic accuracy of Helicobacter pylori in biopsy specimen from patients treated with triple therapy.Am. J. Gastroenterol 61
EFFECT OF CIMETROPIUM BROMIDE ON GALLBLADDER CONTRACTION IN RESPONSE TO ORAL AND INTRADUODENAL OLIVE OIL 61
A “REAL LIVE” EXPERIENCE OF INFLIXIMAB USE FOR CROHN’S DISEASE IN SOUTHERN ITALY 61
Effects of cimetropium bromide on gallbladder contraction in response to oral and intraduodenal olive oil. 61
Registrazione delle 24 ore della motilità del piloro in soggetti normali 60
Role of transient lower esophageal sphincter relaxations in the genesis of priximal gastro-esophageal reflux 60
MIGRATING MOTOR COMPLEX RECORDED SPONTANEOUSLY AND INDUCED BY MOTILIN AND ERYTHROMYCIN IN AN EX VIVO RABBIT INTESTINAL PREPARATION 60
EFFECT OF HYOSCINE N-BUTYLBROMIDE ON GASTROESOPHAGEAL REFLUX IN NORMAL SUBJECTS AND PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE. 60
EFFECT OF THE 5-HT1 AGONIST SUMATRIPTAN ON ESOPHAGEAL MOTOR PATTERN IN PATIENTS WITH INEFFECTIVE ESOPHAGEAL MOTILITY 60
Increase of swallows before the onset of phase III of migrating motor complex in normal human subjects 60
ULTRASOUND(US) GRADED HEPATOSTEATOSIS ASSESSMENT THROUGH CONTRAST ENHANCED ULTRASOUND (CEUS) AND FIBROSCAN IN NON ALCOHOLIC FATTY LIVER DISEASE 60
THE VALUE OF CONTRAST ENHANCED ENDOSCOPIC ULTRASOUND IN THE FINE NEEDLE ASPIRATION 60
Ottimizzazione di vedolizumab in RCU con perdita di risposta a infliximab 60
Gastric antral and fundic distention evaluated by ultrasonography (US) in normal subjects and patients with idiopathic dyspepsia 59
EFFICACIA E SICUREZZA DEL RITRATTAMENTO CON INFLIXIMAB IN UN PAZIENTE AFFETTO DA MORBO DI CROHN 59
DISORDINI MOTORI ASPECIFICI DELL’ESOFAGO 59
THE INFLUENCE OF ACID REFLUX ON THE HEART RATE VARIABILITY (HRV) IN PATIENTS WITH AND WITHOUT GASTROESOPHAGEAL REFLUX DISEASE (GERD). 59
ESOPHAGEAL MOTILITY ASSESSMENT AFTER PRUCALOPRIDE ADMINISTRATION IN PATIENTS WITH INEFFECTIVE ESOPHAGEAL MOTILITY (IEM) AND SYSTEMIC SCLEROSIS. 59
Alterazioni contrattili della muscolatura liscia nel corso di colite sperimentale sono ridotte da un antagonista specifico della sostanza P 59
5-HT1-RECEPTOR AGONIST SUMATRIPTAN MODIFIES GASTRIC SIZE AFTER 500 ML OF WATER IN DYSPEPTIC PATIENTS AND NORMAL SUBJECTS 58
EFFECT OF THE 5-HT3 RECEPTOR ANTAGONIST, ONDANSETRON, ON GASTRIC SIZE IN DYSPEPTIC PATIENTS WITH IMPAIRED GASTRIC ACCOMODATION 58
SAFETY OF INFLIXIMAB(IFX) ONE-HOUR INFUSION IN INFLAMMATORY BOWEL DISEASE(IBD): A MULTICENTER STUDY FROM SOUTHERN ITALY 58
GASTRIC AND GALLBLADDER EMPTYING AFTER STANDARD SOLID MEAL IN NORMAL CONTROLS, PATIENTS WITH “MOTILITY-LIKE” DYSPEPSIA AND EFFECT OF DOMPERIDONE. 57
LA MALATTIA DA REFLUSSO GASTROESOFAGEO 57
Prolonged anal sphincter manometry in normal human subjects 56
ON THE SPECIFICITY OF ALTERED MUSCLE FUNCTION IN EXPERIMENTAL COLITIS IN RATS 56
Effect of nitric oxide on propagated clusters of spontaneous motor waves in an ex vivo rabbit intestinal preparation 56
Detection of Helicobacter pylori in esophagus and saliva in humans 56
ROLE OF PRUCALOPRIDE (RESOLOR) IN THE SETTING-UP OF PILLCAM COLON-CAPSULE ENDOSCOPY (CCE). EXPERIENCEFROM A SINGLE CENTRE 56
TRANSIENT LOWER ESOPHAGEAL SPHINCTER RELAXATIONS PLAY AN INSIGNIFICANT ROLE IN GASTRO-ESOPHAGEAL REFLUX TO THE PROXIMAL ESOPHAGUS 55
EFFECT OF AN ACUTE INTRALUMINAL ADMINISTRATION OF CAPSAICIN ON OESOPHAGEAL MOTOR PATTERN IN GORD PATIENTS WITH INEFFECTIVE OESOPHAGAL MOTILITY 55
EFFECT OF BACLOFEN ON ESOPHAGEAL MOTILITY AND TRANSIENT LOWER ESOPHAGEAL SPHINCTER RELAXATIONS IN GERD PATIENTS: A 48-HOUR MANOMETRIC STUDY 55
LACTOSE MALABSORPTION (LM) AND IRRITABLE BOWEL SYNDROME (IBS): INCIDENCE AND EVALUATION OF SYMPTOMS 55
Studio funzionale delle resezioni rettali basse. 55
CAN HELICOBACTER PYLORI INFECTION HAVE A ROLE ON CLINICAL APPEARANCE OF GERD? 55
CLINICAL AND ECONOMIC IMPACT OF INFLIXIMAB ONE-HOUR INFUSION PROTOCOL IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES: A MULTICENTER STUDY 55
Effect of cimetropium bromide on esophageal motility and transit in patients affected by primary achalasia. 54
PRUCALOPRIDE ACCELERATES GASTRIC AND SMALL BOWEL TRANSIT TIMES OF VIDEOCAPSULES ENDOSCOPY 54
Totale 6930
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16891
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16891
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018343 0000 00 00 604019944
2018/20191118 12262130 37136 19829 262519325
2019/20202443 6621511679 208329 351270 431242037
2020/2021983 163318217 82227 1823 301352182
2021/2022789 35154200 4616 2466 54988232
2022/20232043 188207108264 194488 178162 254000
Totale 9880